Clinical Trials on Breast Cancer With Low to Intermediate HER2 Expression in Switzerland

Total 1 results

  • Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
    Recruiting
    DESTINY Breast Respond HER2-low Europe
    Metastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast Cancer
    Austria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe